Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York

Journal of Infectious Diseases

Volumn 194, Issue 4, 2006, Pages 428-434

  Luque, Amneris E ^a,c   Jabeen, Musaret ^a,b   Messing, Susan ^a   Lane, Christopher A ^a   Demeter, Lisa M ^a   Rose, Robert C ^a   Reichman, Richard C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b National Heart Lung/Blood Institute   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA; WART VIRUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG DESIGN; ENDOMETRIUM CARCINOMA; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE MM7; HUMAN PAPILLOMAVIRUS TYPE MM8; MAJOR CLINICAL STUDY; NONHUMAN; PARAKERATOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS CELL; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS GENE; VIRUS PATHOGENESIS; WART VIRUS;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; NEW YORK; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; PREVALENCE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33746722064     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505876     Document Type: Article

References (17)

1. zur Hausen H. Viruses in human cancers. Science 1991; 254:1167-73.
2. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-64.
3. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl I Med 2003; 348:518-27.
4. Vermund SH, Kelley KF, Klein RS, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991; 165:392-400.
5. Wright TC, Moscarelli RD, Dole P, Ellerbrock TV, Chiasson MA, Vandevanter N. Clinical significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996; 87:515-9.
6. Sun XW, Kuhn L, Ellerbrock TV, Chaisson MA, Wright TC. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337:1343-9.
7. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003; 189:295-304.
8. Poljak M, Marin IJ, Seme K, Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 2002; 25(Suppl 3):S89-97.
9. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 HPV types from L1 consensus PCR products using a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36:3020-7.
10. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-61.
11. Luque AE, Demeter LM, Reichman RC. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection. J Infect Dis 1999; 179:1405-9.
12. Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003; 95:1062-71.
13. Levi JE, Kleter B, Quint WGV, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40:3341-5.
14. Levi JE, Fernandez S, Tateno AF, et al. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004; 92:225-31.
15. La Ruche G, You B, Mensah-Ado I, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998; 76:480-6.
16. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645-51.
17. Harper DM, Franco EL, Wheeler C, et al. Efficacy of bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004; 364:1757-65.